Efficacy of intravitreal bevacizumab as adjunctive treatment with pars plana vitrectomy, endolaser photocoagulation, and trabeculectomy for neovascular glaucoma

Br J Ophthalmol. 2008 Oct;92(10):1431-3. doi: 10.1136/bjo.2007.129833.
No abstract available

Publication types

  • Case Reports
  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antibodies, Monoclonal / therapeutic use*
  • Antibodies, Monoclonal, Humanized
  • Bevacizumab
  • Combined Modality Therapy
  • Female
  • Glaucoma, Neovascular / drug therapy*
  • Glaucoma, Neovascular / surgery*
  • Humans
  • Intraocular Pressure / drug effects
  • Laser Coagulation / methods*
  • Male
  • Middle Aged
  • Retinal Hemorrhage / prevention & control
  • Trabeculectomy / methods*
  • Treatment Outcome
  • Vitrectomy / methods*

Substances

  • Antibodies, Monoclonal
  • Antibodies, Monoclonal, Humanized
  • Bevacizumab